By Colin Kellaher
Merck & Co. plans to invest $895 million to expand its animal-health operations in De Soto, Kan.
Merck on Thursday said the move includes an $860 million investment in its existing biologics manufacturing facility, along with a $35 million investment in its research-and-development laboratories.
The Rahway, N.J., drug maker said the 200,000-square-foot manufacturing facility project will expand filling and freeze dryer capacity for large molecule vaccines and biologic products for its Merck Animal Health unit, which accounted for roughly 10% of the company's first-quarter sales of more than $15.5 billion.
Merck said site preparation and facility design will start immediately, creating 2,500 construction jobs, with commercial manufacturing slated to begin in 2030, creating more than 200 full-time roles.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
May 08, 2025 09:17 ET (13:17 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。